Endobronchial plasmacytoma in patient with multiple myeloma.
Sunnetcioglu A et al. Clin Respir J. 2015 Oct 27. doi: 10.1111/crj.12408. [Epub ahead of print].

Rapid Progression of Vascular and Soft Tissue Calcification while Being Managed for Severe and Persistent Hypocalcemia Induced by Denosumab Treatment in a Patient with Multiple Myeloma and Chronic Kidney Disease.
Ueki K et al. Intern Med. 2015;54(20):2637-42. doi: 10.2169/internalmedicine.54.4946. Epub 2015 Oct 15.

Neutrophil dermatosis of the dorsal hands with multiple myeloma.
Fauconnier SA et al. Joint Bone Spine. 2015 Oct 6. pii: S1297-319X(15)00158-X. doi: 10.1016/j.jbspin.2015.03.011. [Epub ahead of print].

Muscle Hypertrophy in a Patient with Immunoglobulin D Multiple Myeloma.
Suzuki S et al. J Gen Intern Med. 2015 Oct 8. [Epub ahead of print].

Renal extramedullary hematopoiesis: interstitial and glomerular pathology.
Alexander MP et al. Mod Pathol. 2015 Oct 9. doi: 10.1038/modpathol.2015.117. [Epub ahead of print].

Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients with hematological malignancies.
Han JW et al. Hepatol Res. 2015 Oct 7. doi: 10.1111/hepr.12603. [Epub ahead of print].

Musculoskeletal complications of haematological disease.
Morais SA et al. Rheumatology (Oxford). 2015 Oct 5. pii: kev360. [Epub ahead of print].

Cutaneous and pleural involvement in a patient with multiple myeloma.
Saidane O et al. BMJ Case Rep. 2015 Oct 5;2015. pii: bcr2015211197. doi: 10.1136/bcr-2015-211197.

Infectious complications in patients with newly diagnosed multiple myeloma: A complication from the past?
de la Rubia J et al.Leuk Lymphoma. 2015 Oct 1:1-31. [Epub ahead of print].

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.
Katodritou E et al. Ann Hematol. 2015 Dec;94(12):2033-42. doi: 10.1007/s00277-015-2484-y. Epub 2015 Sep 30.

Thrombotic microangiopathy associated with proteasome inhibitors.
Lodhi A et al. Clin Kidney J. 2015 Oct;8(5):632-6. doi: 10.1093/ckj/sfv059. Epub 2015 Jul 16